SimFlex Competitors

Simulations Plus is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. We offer solutions that bridge artificial intelligence (AI) and machine learning (ML), physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, and consumer goods companies, and regulatory agencies worldwide. For more information visit us at www.simulations-plus.com

Mendel AI supercharges clinical data workflows by coupling large language models with a proprietary clinical hypergraph, delivering scalable clinical reasoning without hallucinations and ensuring 100% explainability. Headquartered in San Jose, California, Mendel is backed by blue-chip investors, including Oak HC/FT and DCM.

Maplesoft has provided mathematics-based software solutions to educators, engineers, and researchers in science, technology, engineering, and mathematics (STEM) for over 35 years. Maplesoft’s flagship product, Maple, combines the world’s most powerful mathematics engine with an interface that makes it extremely easy to analyze, explore, visualize, and solve mathematical problems. Building on this technology, the product line includes solutions for math education and student success, engineering calculation management, and modeling and simulation of complex multidomain systems such as roll-to-roll web converting systems. Maplesoft products provide modern, innovative solutions to meet today’s challenges, from exploring math concepts on a smartphone to reducing development risk in complex engineering design projects. Maplesoft products and services are used by more than 8000 educational institutions, research labs, and companies, in over 90 countries. Maplesoft is a subsidiary of Cybernet Systems Group.